
Rachel B. Weil
Never Say Daubert Again: Amendments to Fed. R. Evid. 702 Unanimously Approved
Drug & Device Law ·
Design Defect Claim Dismissed in W.D.N.Y. Fosamax Case
Drug & Device Law ·
Mostly Good Preemption Decision Out of the District of Columbia
Drug & Device Law ·